Φορτώνει......
Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitors
Coactivator-associated arginine methyltransferase 1 (CARM1)-expressing high-grade serous ovarian cancers are characterized by poor prognosis and limited therapeutic options. Here we discuss a novel therapeutic strategy to target CARM1-expressing ovarian cancer based on a combination of poly (ADP-rib...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Cell Oncol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469455/ https://ncbi.nlm.nih.gov/pubmed/32944622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1760675 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|